Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Mir-216 Is a Key Regulator and Potential Marker in Human Cancers Publisher



M Mondeali MOZHGAN ; F Mozaffari FATEMEH ; P Ghiasizadeh POORAN ; S Bakhti SANAZ ; M Salehi MARJAN ; N Kamali NAVID ; M Rafat MILAD
Authors

Source: Advanced Biomedical Research Published:2025


Abstract

MicroRNAs, a class of small noncoding RNAs, have been identified as promising biomarkers for cancer identification and management by regulating gene expression and other cellular biological pathways. This review gathers findings for understanding the molecular basis and clinical importance of microRNA-216 (miR-216) in several cancers. Increased or decreased expression of miR-216 has been observed in a variety of cancers, including esophageal cancer, breast cancer, colorectal cancer, gastric cancer, pancreatic cancer, cervical cancer, brain tumor (glioma), prostate cancer, and acute myeloid leukemia, indicating its activity as an oncogene or tumor suppressor. Through this study, we proposed that miR-216 can potentially be a candidate as a prognostic marker for early detection of tumor development, progression, as well as metastasis in cancer patients. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Role of Non-Coding Rnas in Neuroblastoma, Cancer Gene Therapy (2023)
2. Microrna-203 Reinforces Stemness Properties in Melanoma and Augments Tumorigenesis in Vivo, Journal of Cellular Physiology (2019)
3. Microrna Expression Levels and Histopathological Features of Colorectal Cancer, Journal of Gastrointestinal Cancer (2019)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (3)
Habibollah Mahmoodzadeh (2)
Other Related Docs
4. Microrna-146 Family: Molecular Insights Into Their Role in Regulation of Signaling Pathways in Glioma Progression, Pathology, research and practice (2024)
5. Pten and Mir-26B: Promising Prognostic Biomarkers in Initiation and Progression of Oral Squamous Cell Carcinoma, Journal of Oral Pathology and Medicine (2019)
6. Micrornas As Potential Diagnostic and Prognostic Biomarkers in Melanoma, European Journal of Cancer (2016)
7. The Role of Oncomirs in the Pathogenesis and Treatment of Breast Cancer, Biomedicine and Pharmacotherapy (2016)
8. Microrna As a Potential Diagnostic and Prognostic Biomarker in Brain Gliomas: A Systematic Review and Meta-Analysis, Frontiers in Neurology (2024)
9. Diagnostic, Prognostic, and Therapeutic Significance of Mir-139-5P in Cancers, Life Sciences (2020)
10. Circulating Levels of the Mirnas, Mir-194, and Mir-29B, As Clinically Useful Biomarkers for Colorectal Cancer, Tumor Biology (2016)
11. Microrna-181 Serves As a Dual-Role Regulator in the Development of Human Cancers, Free Radical Biology and Medicine (2020)
12. Dysregulated Expression of Mir-146A and Its Associated Immune Effectors in Peripheral Blood Mononuclear Cells of Esophageal Carcinoma Patients, Immunological Investigations (2022)
13. Downregulation of Plasma Mir-142-3P and Mir-26A-5P in Patients With Colorectal Carcinoma, International Journal of Cancer Management (2015)
14. Long Non-Coding Rnas (Lncrnas); Roles in Tumorigenesis and Potentials As Biomarkers in Cancer Diagnosis, Experimental Cell Research (2022)
15. The Mir-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting Egfr Oncogenic Signaling Pathway, Iranian Journal of Pharmaceutical Research (2021)
16. Micrornas in Non-Malignant Diseases, Synthesis Lectures on Biomedical Engineering (2022)
17. Regulation and Function of Microrna-152 in Various Types of Cancers: Its Upstream Regulators and Downstream Targets, Clinical and Experimental Medicine (2025)
18. Biological Function and Molecular Mechanism of Pirna in Cancer, Practical Laboratory Medicine (2019)
19. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
20. An Overview of Micrornas: Biology, Functions, Therapeutics, and Analysis Methods, Journal of Cellular Physiology (2019)